Evergreen Capital Management’s Colgate-Palmolive CL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.03M | Buy |
11,231
+1,696
| +18% | +$148K | 0.02% | 525 |
|
|
2026
Q1 | $813K | Buy |
9,535
+4,854
| +104% | +$433K | 0.02% | 559 |
|
|
2025
Q4 | $370K | Sell |
4,681
-225
| -5% | -$17.6K | 0.01% | 917 |
|
|
2025
Q3 | $392K | Buy |
4,906
+337
| +7% | +$28.7K | 0.01% | 783 |
|
|
2025
Q2 | $415K | Buy |
4,569
+171
| +4% | +$15.6K | 0.01% | 645 |
|
|
2025
Q1 | $412K | Buy |
4,398
+1,903
| +76% | +$170K | 0.01% | 584 |
|
|
2024
Q4 | $227K | Sell |
2,495
-487
| -16% | -$46.5K | 0.01% | 902 |
|
|
2024
Q3 | $310K | Sell |
2,982
-508
| -15% | -$51.8K | 0.01% | 696 |
|
|
2024
Q2 | $339K | Buy |
3,490
+141
| +4% | +$13K | 0.01% | 615 |
|
|
2024
Q1 | $302K | Sell |
3,349
-203
| -6% | -$17.2K | 0.01% | 629 |
|
|
2023
Q4 | $283K | Sell |
3,552
-1,386
| -28% | -$104K | 0.01% | 617 |
|
|
2023
Q3 | $351K | Sell |
4,938
-457
| -8% | -$34.2K | 0.02% | 503 |
|
|
2023
Q2 | $416K | Sell |
5,395
-71
| -1% | -$5.5K | 0.02% | 440 |
|
|
2023
Q1 | $411K | Buy |
5,466
+1,212
| +28% | +$90.1K | 0.02% | 418 |
|
|
2022
Q4 | $335K | Buy |
4,254
+798
| +23% | +$59.8K | 0.02% | 452 |
|
|
2022
Q3 | $242K | Buy |
3,456
+606
| +21% | +$47.5K | 0.01% | 500 |
|
|
2022
Q2 | $228K | Sell |
2,850
-3,859
| -58% | -$302K | 0.01% | 492 |
|
|
2022
Q1 | $509K | Buy |
6,709
+315
| +5% | +$25K | 0.02% | 374 |
|
|
2021
Q4 | $546K | Buy |
6,394
+1,762
| +38% | +$138K | 0.02% | 361 |
|
|
2021
Q3 | $350K | Buy |
4,632
+1,712
| +59% | +$136K | 0.02% | 406 |
|
|
2021
Q2 | $238K | Buy |
2,920
+158
| +6% | +$12.9K | 0.01% | 465 |
|
|
2021
Q1 | $218K | Sell |
2,762
-967
| -26% | -$75.8K | 0.01% | 462 |
|
|
2020
Q4 | $319K | Buy |
3,729
+22
| +0.6% | +$1.82K | 0.02% | 336 |
|
|
2020
Q3 | $286K | Buy |
3,707
+112
| +3% | +$8.54K | 0.02% | 335 |
|
|
2020
Q2 | $263K | Sell |
3,595
-180
| -5% | -$12.8K | 0.02% | 328 |
|
|
2020
Q1 | $251K | Buy |
3,775
+186
| +5% | +$13.1K | 0.02% | 300 |
|
|
2019
Q4 | $247K | Buy |
+3,589
| New | +$245K | 0.02% | 383 |
|
|
2019
Q3 | – | Sell |
-2,787
| Closed | -$200K | – | 431 |
|
|
2019
Q2 | $200K | Buy |
+2,787
| New | +$198K | 0.02% | 395 |
|
|
2018
Q2 | – | Sell |
-3,153
| Closed | -$226K | – | 373 |
|
|
2018
Q1 | $226K | Buy |
+3,153
| New | +$227K | 0.02% | 313 |
|
Other funds holding CL
Evergreen Capital Management's CL Position: Q2 2026 in Review
Evergreen Capital Management increased its Colgate-Palmolive (CL) stake by 18% in Q2 2026, buying an estimated $148K and bringing the position to 11,231 shares worth $1.03M. The position accounts for 0.02% of the portfolio, ranked #525.
Evergreen Capital Management first reported a position in CL in Q1 2018 and has held it in 29 quarters since. 2,028 funds tracked by Wall St. Rank hold CL as of Q2 2026.
- Evergreen Capital Management held 11,231 shares of Colgate-Palmolive worth $1.03M as of Q2 2026.
- Evergreen Capital Management bought 1,696 Colgate-Palmolive shares in Q2 2026, an estimated $148K.
- Colgate-Palmolive made up 0.02% of Evergreen Capital Management's portfolio in Q2 2026, its #525 holding.
- Evergreen Capital Management first reported a position in Colgate-Palmolive in Q1 2018 and has held it in 29 quarters since.
- 2,028 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.
Based on Evergreen Capital Management's 13F filing for Q2 2026, filed 23 Jul 2026.